Browsing Tag
Quoin Pharmaceuticals Ltd.
2 posts
Quoin Pharmaceuticals (NASDAQ: QNRX) spikes over 50% after rapamycin breakthrough in rare disease program
Quoin Pharmaceuticals (NASDAQ: QNRX) stock surged over 50% after achieving key rapamycin delivery targets. Find out how this positions its rare disease pipeline.
QRX003 by Quoin Pharmaceuticals earns FDA orphan drug designation, signaling hope for Netherton Syndrome patients
Find out how Quoin Pharmaceuticals is changing rare-disease treatment today with its QRX003 orphan drug win — read more now!